8 research outputs found
Π ΠΎΡΡΠΈΠΉΡΠΊΠΈΠΉ ΠΎΠΏΡΡ ΡΡΠ°Π½ΡΠΏΠΎΡΡΠ½ΠΎΠΉ ΡΠΊΡΡΡΠ°ΠΊΠΎΡΠΏΠΎΡΠ°Π»ΡΠ½ΠΎΠΉ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½Π½ΠΎΠΉ ΠΎΠΊΡΠΈΠ³Π΅Π½Π°ΡΠΈΠΈ
Relevance. The present time can be called a period of accumulation of experience of national health systems in different countries of the world in the application of transport extracorporeal membrane oxygenation (ECMO) technology at the pre- and inter-hospital stages of evacuation of patients to specialized ECMO-therapy centers. The role of such centers is to provide timely advice and, if necessary, perform inter-hospital evacuation.Material and methods. The study summarized and analyzed with the help of the national register βRosECMOβ the own experience of 13 hospitals in the Russian Federation, who performed 68 inter-hospital evacuations under ECMO conditions by different modes of transport in patients of different age groups with symptoms of circulatory and respiratory failure. The following parameters were evaluated: characteristics of transport ECMO, clinical manifestations of potentially negative effects of transport, hospital survival, as well as the effect of experience (less and more than 10 cases of transport ECMO) of the presented clinics on the difference in the results obtained.Results. Connecting patients to the ECMO device reduces the likelihood of death on the SOFA and APACHE IV scales by 1.2 times (p <0.0001) and 1.4 times (p<0.0001), respectively. Despite the absence of deaths during inter-hospital transportation of patients under ECMO conditions, 14.93% of patients died within 3 days from the moment of their execution, without a significant difference in clinics with different practical experience. The overall hospital survival rate of ECMO transport scenarios in all 13 clinics of the Russian Federation was comparable to the data of the international register 48.52% versus 48.81%, at the same time it was significantly lower (1.3 times) in the group of clinics with less clinical experience 40% versus 52.08% (p<0.0001).Conclusion. The results of the first stage of the study we obtained indicate the prospects of using the method of extracorporeal membrane oxygenation at the stage of inter-hospital evacuation, due to the effective stabilization of the patientβs condition and a significant reduction in the risks of the likelihood of death. Clinics with less clinical experience showed significantly worse results of hospital survival of patients who underwent inter-hospital transportation under conditions of extracorporeal membrane oxygenation compared to clinics with more clinical experience, which can be a significant argument in adopting a model for the development of specialized regional centers for extracorporeal membrane oxygenation. The experience accumulated over the past six years and the analysis of new data from the register of transport cases of extracorporeal membrane oxygenation of the national healthcare system will make it possible to formulate the correct trajectory for the development of the method of extracorporeal membrane oxygenation and its application, including at the stage of pre- and inter-hospital evacuations of patients.ΠΠΊΡΡΠ°Π»ΡΠ½ΠΎΡΡΡ. ΠΠ°ΡΡΠΎΡΡΠ΅Π΅ Π²ΡΠ΅ΠΌΡ ΠΌΠΎΠΆΠ½ΠΎ Π½Π°Π·Π²Π°ΡΡ ΠΏΠ΅ΡΠΈΠΎΠ΄ΠΎΠΌ Π½Π°ΠΊΠΎΠΏΠ»Π΅Π½ΠΈΡ ΠΎΠΏΡΡΠ° Π½Π°ΡΠΈΠΎΠ½Π°Π»ΡΠ½ΡΡ
ΡΠΈΡΡΠ΅ΠΌ Π·Π΄ΡΠ°Π²ΠΎΠΎΡ
ΡΠ°Π½Π΅Π½ΠΈΡ Π² ΡΠ°Π·Π½ΡΡ
ΡΡΡΠ°Π½Π°Ρ
ΠΌΠΈΡΠ° ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΡΠ΅Ρ
Π½ΠΎΠ»ΠΎΠ³ΠΈΠΈ ΡΡΠ°Π½ΡΠΏΠΎΡΡΠ½ΠΎΠΉ ΡΠΊΡΡΡΠ°ΠΊΠΎΡΠΏΠΎΡΠ°Π»ΡΠ½ΠΎΠΉ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½Π½ΠΎΠΉ ΠΎΠΊΡΠΈΠ³Π΅Π½Π°ΡΠΈΠΈ (ΠΠΠΠ) Π½Π° Π΄ΠΎΠΈ ΠΌΠ΅ΠΆΠ³ΠΎΡΠΏΠΈΡΠ°Π»ΡΠ½ΠΎΠΌ ΡΡΠ°ΠΏΠ°Ρ
ΡΠ²Π°ΠΊΡΠ°ΡΠΈΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π² ΡΠΏΠ΅ΡΠΈΠ°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Π½ΡΠ΅ ΡΠ΅Π½ΡΡΡ ΠΠΠΠ-ΡΠ΅ΡΠ°ΠΏΠΈΠΈ. Π ΠΎΠ»Ρ ΠΏΠΎΠ΄ΠΎΠ±Π½ΡΡ
ΡΠ΅Π½ΡΡΠΎΠ² Π·Π°ΠΊΠ»ΡΡΠ°Π΅ΡΡΡ Π² ΡΠ²ΠΎΠ΅Π²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΠΌ ΠΎΠΊΠ°Π·Π°Π½ΠΈΠΈ ΠΊΠΎΠ½ΡΡΠ»ΡΡΠ°ΡΠΈΠ²Π½ΠΎΠΉ ΠΏΠΎΠΌΠΎΡΠΈ, Π° ΠΏΡΠΈ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎΡΡΠΈ ΠΈ Π²ΡΠΏΠΎΠ»Π½Π΅Π½ΠΈΠΈ ΠΌΠ΅ΠΆΠ³ΠΎΡΠΏΠΈΡΠ°Π»ΡΠ½ΠΎΠΉ ΡΠ²Π°ΠΊΡΠ°ΡΠΈΠΈ.ΠΠ°ΡΠ΅ΡΠΈΠ°Π» ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. Π ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΈ ΠΎΠ±ΠΎΠ±ΡΠ΅Π½ ΠΈ ΠΏΡΠΎΠ°Π½Π°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½ Ρ ΠΏΠΎΠΌΠΎΡΡΡ Π½Π°ΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠ΅Π³ΠΈΡΡΡΠ° Β«Π ΠΎΡΠΠΠΠΒ» ΡΠΎΠ±ΡΡΠ²Π΅Π½Π½ΡΠΉ ΠΎΠΏΡΡ 13 ΡΡΠ°ΡΠΈΠΎΠ½Π°ΡΠΎΠ² Π Π€, Π²ΡΠΏΠΎΠ»Π½ΠΈΠ²ΡΠΈΡ
68 ΠΌΠ΅ΠΆΠ³ΠΎΡΠΏΠΈΡΠ°Π»ΡΠ½ΡΡ
ΡΠ²Π°ΠΊΡΠ°ΡΠΈΠΉ Π² ΡΡΠ»ΠΎΠ²ΠΈΡΡ
ΠΠΠΠ ΡΠ°Π·Π½ΡΠΌΠΈ Π²ΠΈΠ΄Π°ΠΌΠΈ ΡΡΠ°Π½ΡΠΏΠΎΡΡΠ° Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΡΠ°Π·Π½ΡΡ
Π²ΠΎΠ·ΡΠ°ΡΡΠ½ΡΡ
Π³ΡΡΠΏΠΏ Ρ ΡΠ²Π»Π΅Π½ΠΈΡΠΌΠΈ ΡΠΈΡΠΊΡΠ»ΡΡΠΎΡΠ½ΠΎΠΉ ΠΈ Π΄ΡΡ
Π°ΡΠ΅Π»ΡΠ½ΠΎΠΉ Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΎΡΠ½ΠΎΡΡΠΈ. ΠΡΠ»ΠΈ ΠΎΡΠ΅Π½Π΅Π½Ρ: Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΡΡΠΈΠΊΠΈ ΡΡΠ°Π½ΡΠΏΠΎΡΡΠ½ΠΎΠ³ΠΎ ΠΠΠΠ, ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΡΠΎΡΠ²Π»Π΅Π½ΠΈΡ ΠΏΠΎΡΠ΅Π½ΡΠΈΠ°Π»ΡΠ½ΠΎ Π½Π΅Π³Π°ΡΠΈΠ²Π½ΠΎΠ³ΠΎ Π²ΠΎΠ·Π΄Π΅ΠΉΡΡΠ²ΠΈΡ ΡΡΠ°Π½ΡΠΏΠΎΡΡΠΈΡΠΎΠ²ΠΊΠΈ, Π³ΠΎΡΠΏΠΈΡΠ°Π»ΡΠ½Π°Ρ Π²ΡΠΆΠΈΠ²Π°Π΅ΠΌΠΎΡΡΡ, Π° ΡΠ°ΠΊΠΆΠ΅ Π²Π»ΠΈΡΠ½ΠΈΠ΅ ΠΎΠΏΡΡΠ° (ΠΌΠ΅Π½ΡΡΠ΅ ΠΈ Π±ΠΎΠ»ΡΡΠ΅ 10 ΡΠ»ΡΡΠ°Π΅Π² ΡΡΠ°Π½ΡΠΏΠΎΡΡΠ½ΠΎΠ³ΠΎ ΠΠΠΠ) ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½Π½ΡΡ
ΠΊΠ»ΠΈΠ½ΠΈΠΊ Π½Π° ΡΠ°Π·Π½ΠΈΡΡ ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΡ
ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ².Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΠΎΠ΄ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΠΊ Π°ΠΏΠΏΠ°ΡΠ°ΡΡ ΠΠΠΠ ΡΠ½ΠΈΠΆΠ°Π΅Ρ Π²Π΅ΡΠΎΡΡΠ½ΠΎΡΡΡ ΡΠΌΠ΅ΡΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΠΈΡΡ
ΠΎΠ΄Π° ΠΏΠΎ ΡΠΊΠ°Π»Π°ΠΌ SOFA ΠΈ APACHE IV Π² 1,2 ΡΠ°Π·Π° (p<0,0001) ΠΈ 1,4 ΡΠ°Π·Π° (p<0,0001) ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²Π΅Π½Π½ΠΎ. ΠΠ΅ΡΠΌΠΎΡΡΡ Π½Π° ΠΎΡΡΡΡΡΡΠ²ΠΈΠ΅ ΡΠΌΠ΅ΡΡΠ΅Π»ΡΠ½ΡΡ
ΠΈΡΡ
ΠΎΠ΄ΠΎΠ² Π² Ρ
ΠΎΠ΄Π΅ ΠΎΡΡΡΠ΅ΡΡΠ²Π»Π΅Π½ΠΈΡ ΠΌΠ΅ΠΆΠ³ΠΎΡΠΏΠΈΡΠ°Π»ΡΠ½ΡΡ
ΡΡΠ°Π½ΡΠΏΠΎΡΡΠΈΡΠΎΠ²ΠΎΠΊ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π² ΡΡΠ»ΠΎΠ²ΠΈΡΡ
ΠΠΠΠ, Π² ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ 3 ΡΡΡΠΎΠΊ ΠΎΡ ΠΌΠΎΠΌΠ΅Π½ΡΠ° ΠΈΡ
Π²ΡΠΏΠΎΠ»Π½Π΅Π½ΠΈΡ ΡΠΌΠ΅ΡΠ»ΠΈ 14,93% ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π±Π΅Π· ΡΡΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΠΉ ΡΠ°Π·Π½ΠΈΡΡ Π² ΠΊΠ»ΠΈΠ½ΠΈΠΊΠ°Ρ
Ρ ΡΠ°Π·Π½ΡΠΌ ΠΏΡΠ°ΠΊΡΠΈΡΠ΅ΡΠΊΠΈΠΌ ΠΎΠΏΡΡΠΎΠΌ. ΠΠ±ΡΠ°Ρ Π³ΠΎΡΠΏΠΈΡΠ°Π»ΡΠ½Π°Ρ Π²ΡΠΆΠΈΠ²Π°Π΅ΠΌΠΎΡΡΡ ΡΡΠ°Π½ΡΠΏΠΎΡΡΠ½ΡΡ
ΡΡΠ΅Π½Π°ΡΠΈΠ΅Π² ΠΠΠΠ Π²ΠΎ Π²ΡΠ΅Ρ
13 ΠΊΠ»ΠΈΠ½ΠΈΠΊΠ°Ρ
Π Π€ ΠΎΠΊΠ°Π·Π°Π»Π°ΡΡ ΡΠΎΠΏΠΎΡΡΠ°Π²ΠΈΠΌΠ° Ρ Π΄Π°Π½Π½ΡΠΌΠΈ ΠΌΠ΅ΠΆΠ΄ΡΠ½Π°ΡΠΎΠ΄Π½ΠΎΠ³ΠΎ ΡΠ΅Π³ΠΈΡΡΡΠ° 48,52% ΠΏΡΠΎΡΠΈΠ² 48,81%, Π² ΡΠΎ ΠΆΠ΅ Π²ΡΠ΅ΠΌΡ Π±ΡΠ»Π° Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎ Π½ΠΈΠΆΠ΅ (Π² 1,3 ΡΠ°Π·Π°) Π² Π³ΡΡΠΏΠΏΠ΅ ΠΊΠ»ΠΈΠ½ΠΈΠΊ Ρ ΠΌΠ΅Π½ΡΡΠΈΠΌ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΌ ΠΎΠΏΡΡΠΎΠΌ 40% ΠΏΡΠΎΡΠΈΠ² 52,08% (p<0,0001).ΠΡΠ²ΠΎΠ΄Ρ. ΠΠΎΠ»ΡΡΠ΅Π½Π½ΡΠ΅ Π½Π°ΠΌΠΈ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΏΠ΅ΡΠ²ΠΎΠ³ΠΎ ΡΡΠ°ΠΏΠ° ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ Π³ΠΎΠ²ΠΎΡΡΡ ΠΎ ΠΏΠ΅ΡΡΠΏΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΌΠ΅ΡΠΎΠ΄Π° ΡΠΊΡΡΡΠ°ΠΊΠΎΡΠΏΠΎΡΠ°Π»ΡΠ½ΠΎΠΉ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½Π½ΠΎΠΉ ΠΎΠΊΡΠΈΠ³Π΅Π½Π°ΡΠΈΠΈ Π½Π° ΡΡΠ°ΠΏΠ΅ ΠΌΠ΅ΠΆΠ³ΠΎΡΠΏΠΈΡΠ°Π»ΡΠ½ΠΎΠΉ ΡΠ²Π°ΠΊΡΠ°ΡΠΈΠΈ, Π·Π° ΡΡΠ΅Ρ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΠΉ ΡΡΠ°Π±ΠΈΠ»ΠΈΠ·Π°ΡΠΈΠΈ ΡΠΎΡΡΠΎΡΠ½ΠΈΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ° ΠΈ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎΠ³ΠΎ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΡ ΡΠΈΡΠΊΠΎΠ² Π²Π΅ΡΠΎΡΡΠ½ΠΎΡΡΠΈ Π»Π΅ΡΠ°Π»ΡΠ½ΠΎΠ³ΠΎ ΠΈΡΡ
ΠΎΠ΄Π°. ΠΠ»ΠΈΠ½ΠΈΠΊΠΈ Ρ ΠΌΠ΅Π½ΡΡΠΈΠΌ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΌ ΠΎΠΏΡΡΠΎΠΌ ΠΏΠΎΠΊΠ°Π·Π°Π»ΠΈ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎ Ρ
ΡΠ΄ΡΠΈΠ΅ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΡ Π³ΠΎΡΠΏΠΈΡΠ°Π»ΡΠ½ΠΎΠΉ Π²ΡΠΆΠΈΠ²Π°Π΅ΠΌΠΎΡΡΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ², ΠΊΠΎΡΠΎΡΡΠΌ Π²ΡΠΏΠΎΠ»Π½ΡΠ»ΠΈ ΠΌΠ΅ΠΆΠ³ΠΎΡΠΏΠΈΡΠ°Π»ΡΠ½ΡΡ ΡΡΠ°Π½ΡΠΏΠΎΡΡΠΈΡΠΎΠ²ΠΊΡ Π² ΡΡΠ»ΠΎΠ²ΠΈΡΡ
ΡΠΊΡΡΡΠ°ΠΊΠΎΡΠΏΠΎΡΠ°Π»ΡΠ½ΠΎΠΉ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½Π½ΠΎΠΉ ΠΎΠΊΡΠΈΠ³Π΅Π½Π°ΡΠΈΠΈ ΠΏΠΎ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ Ρ ΠΊΠ»ΠΈΠ½ΠΈΠΊΠ°ΠΌΠΈ Ρ Π±ΠΎΠ»ΡΡΠΈΠΌ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΌ ΠΎΠΏΡΡΠΎΠΌ, ΡΡΠΎ ΠΌΠΎΠΆΠ΅Ρ Π±ΡΡΡ Π·Π½Π°ΡΠΈΠΌΡΠΌ Π°ΡΠ³ΡΠΌΠ΅Π½ΡΠΎΠΌ Π² ΠΏΡΠΈΠ½ΡΡΠΈΠ΅ ΠΌΠΎΠ΄Π΅Π»ΠΈ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΡΠΏΠ΅ΡΠΈΠ°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
ΡΠ΅Π³ΠΈΠΎΠ½Π°Π»ΡΠ½ΡΡ
ΡΠ΅Π½ΡΡΠΎΠ² ΡΠΊΡΡΡΠ°ΠΊΠΎΡΠΏΠΎΡΠ°Π»ΡΠ½ΠΎΠΉ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½Π½ΠΎΠΉ ΠΎΠΊΡΠΈΠ³Π΅Π½Π°ΡΠΈΠΈ. ΠΠ°ΠΊΠΎΠΏΠ»Π΅Π½Π½ΡΠΉ Π·Π° ΠΏΡΠΎΡΠ΅Π΄ΡΠΈΠ΅ ΡΠ΅ΡΡΡ Π»Π΅Ρ ΠΎΠΏΡΡ ΠΈ Π°Π½Π°Π»ΠΈΠ· Π½ΠΎΠ²ΡΡ
Π΄Π°Π½Π½ΡΡ
ΡΠ΅Π³ΠΈΡΡΡΠ° ΡΡΠ°Π½ΡΠΏΠΎΡΡΠ½ΡΡ
ΡΠ»ΡΡΠ°Π΅Π² ΡΠΊΡΡΡΠ°ΠΊΠΎΡΠΏΠΎΡΠ°Π»ΡΠ½ΠΎΠΉ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½Π½ΠΎΠΉ ΠΎΠΊΡΠΈΠ³Π΅Π½Π°ΡΠΈΠΈ Π½Π°ΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌΡ Π·Π΄ΡΠ°Π²ΠΎΠΎΡ
ΡΠ°Π½Π΅Π½ΠΈΡ ΠΏΠΎΠ·Π²ΠΎΠ»ΠΈΡ ΡΡΠΎΡΠΌΡΠ»ΠΈΡΠΎΠ²Π°ΡΡ ΠΏΡΠ°Π²ΠΈΠ»ΡΠ½ΡΡ ΡΡΠ°Π΅ΠΊΡΠΎΡΠΈΡ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΌΠ΅ΡΠΎΠ΄Π° ΡΠΊΡΡΡΠ°ΠΊΠΎΡΠΏΠΎΡΠ°Π»ΡΠ½ΠΎΠΉ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½Π½ΠΎΠΉ ΠΎΠΊΡΠΈΠ³Π΅Π½Π°ΡΠΈΠΈ ΠΈ Π΅Π³ΠΎ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ Π² ΡΠΎΠΌ ΡΠΈΡΠ»Π΅ Π½Π° ΡΡΠ°ΠΏΠ΅ Π΄ΠΎΠΈ ΠΌΠ΅ΠΆΠ³ΠΎΡΠΏΠΈΡΠ°Π»ΡΠ½ΡΡ
ΡΠ²Π°ΠΊΡΠ°ΡΠΈΠΉ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ²
Π Π΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½Π°Ρ ΡΠ΅ΡΠ°ΠΏΠΈΡ ΠΎΡΡΡΠΎΠ³ΠΎ ΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΠΎΠ³ΠΎ Π΄ΠΈΡΡΡΠ΅ΡΡ-ΡΠΈΠ½Π΄ΡΠΎΠΌΠ° Ρ ΠΊΠ°ΡΠ΄ΠΈΠΎΡ ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ Π±ΠΎΠ»ΡΠ½ΡΡ
The purpose of the present investigation was to improve the outcomes of intensive care in patients with acute respiratory distress syndrome after cardiac surgery under extracorporeal circulation.Materials and methods. Respiratory therapy was analyzed in 43 patients with acute respiratory distress syndrome after surgery under extracorporeal circulation. According to the procedure of artificial ventilation (AV), the patients were divided into 2 groups: 1) those who had undergone routine tracheal intubation (n=23) AND 2) THOSE who had received noninvasive intubation through a nasal mask (n=20). The respiratory parameters, blood gas composition, central hemodynamic parameters, respiratory support time, and the pattern of complications were analyzed.Results. Noninvasive artificial ventilation permits one to make the patients active in earlier periods and take a spontaneous breath, recovers the respiratory index earlier, reduces the level of positive end-expiratory pressure, the frequency of infectious complications of the tracheobronchial tree, and length of stay in an intensive care unit as compared with endotracheal AV.Conclusion. The findings suggest that noninvasive AV is highly effective and yields better results of treatment in patients with acute respiratory distress syndrome.Π¦Π΅Π»ΡΡ Π½Π°ΡΡΠΎΡΡΠ΅Π³ΠΎ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΡΠ²ΠΈΠ»ΠΎΡΡ ΡΠ»ΡΡΡΠ΅Π½ΠΈΠ΅ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ² ΠΈΠ½ΡΠ΅Π½ΡΠΈΠ²Π½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ
Ρ ΠΎΡΡΡΡΠΌ ΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΡΠΌ Π΄ΠΈΡΡΡΠ΅ΡΡ-ΡΠΈΠ½Π΄ΡΠΎΠΌΠΎΠΌ ΠΏΠΎΡΠ»Π΅ ΠΊΠ°ΡΠ΄ΠΈΠΎΡ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΉ Ρ ΠΈΡΠΊΡΡΡΡΠ²Π΅Π½Π½ΡΠΌ ΠΊΡΠΎΠ²ΠΎΠΎΠ±ΡΠ°ΡΠ΅Π½ΠΈΠ΅ΠΌ.ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½ Π°Π½Π°Π»ΠΈΠ· ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΡ ΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ Ρ 43 Π±ΠΎΠ»ΡΠ½ΡΡ
Ρ ΠΎΡΡΡΡΠΌ ΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΡΠΌ Π΄ΠΈΡΡΡΠ΅ΡΡ-ΡΠΈΠ½Π΄ΡΠΎΠΌΠΎΠΌ ΠΏΠΎΡΠ»Π΅ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΉ Ρ ΠΈΡΠΊΡΡΡΡΠ²Π΅Π½Π½ΡΠΌ ΠΊΡΠΎΠ²ΠΎΠΎΠ±ΡΠ°ΡΠ΅Π½ΠΈΠ΅ΠΌ. ΠΠΎΠ»ΡΠ½ΡΠ΅ ΡΠ°Π·Π΄Π΅Π»Π΅Π½Ρ Π½Π° 2 Π³ΡΡΠΏΠΏΡ Π² Π·Π°Π²ΠΈΡΠΈΠΌΠΎΡΡΠΈ ΠΎΡ ΠΌΠ΅ΡΠΎΠ΄Π° ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΡ ΠΠΠ: ΡΡΠ°Π΄ΠΈΡΠΈΠΎΠ½Π½Π°Ρ Ρ ΠΈΠ½ΡΡΠ±Π°ΡΠΈΠ΅ΠΉ ΡΡΠ°Ρ
Π΅ΠΈ (n=23) ΠΈ Π½Π΅ΠΈΠ½Π²Π°Π·ΠΈΠ²Π½Π°Ρ, ΡΠ΅ΡΠ΅Π· Π½Π°Π·Π°Π»ΡΠ½ΡΡ ΠΌΠ°ΡΠΊΡ (n=20). ΠΠ½Π°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π»ΠΈΡΡ ΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΡΠ΅ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ, Π³Π°Π·ΠΎΠ²ΡΠΉ ΡΠΎΡΡΠ°Π² ΠΊΡΠΎΠ²ΠΈ, ΠΏΠ°ΡΠ°ΠΌΠ΅ΡΡΡ ΡΠ΅Π½ΡΡΠ°Π»ΡΠ½ΠΎΠΉ Π³Π΅ΠΌΠΎΠ΄ΠΈΠ½Π°ΠΌΠΈΠΊΠΈ, Π²ΡΠ΅ΠΌΡ ΠΎΠΊΠΎΠ½ΡΠ°Π½ΠΈΡ ΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΠΎΠΉ ΠΏΠΎΠ΄Π΄Π΅ΡΠΆΠΊΠΈ, Ρ
Π°ΡΠ°ΠΊΡΠ΅Ρ ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ.Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ ΠΠΠΠ ΠΏΠΎΠ·Π²ΠΎΠ»ΡΠ΅Ρ Π² Π±ΠΎΠ»Π΅Π΅ ΡΠ°Π½Π½ΠΈΠ΅ ΡΡΠΎΠΊΠΈ Π°ΠΊΡΠΈΠ²ΠΈΠ·ΠΈΡΠΎΠ²Π°ΡΡ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΈ ΠΏΠ΅ΡΠ΅Π²Π΅ΡΡΠΈ ΠΈΡ
Π½Π° ΡΠ°ΠΌΠΎΡΡΠΎΡΡΠ΅Π»ΡΠ½ΠΎΠ΅ Π΄ΡΡ
Π°Π½ΠΈΠ΅, Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΠ·ΡΠ΅ΡΡΡ Π±ΠΎΠ»Π΅Π΅ ΡΠ°Π½Π½ΠΈΠΌ Π²ΠΎΡΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΈΠ΅ΠΌ ΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΠΎΠ³ΠΎ ΠΈΠ½Π΄Π΅ΠΊΡΠ° ΠΈ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΠ΅ΠΌ ΡΡΠΎΠ²Π½Ρ ΠΠΠΠ, ΠΌΠ΅Π½ΡΡΠ΅ΠΉ ΡΠ°ΡΡΠΎΡΠΎΠΉ Π³Π½ΠΎΠΉΠ½ΠΎ-ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΎΠ½Π½ΡΡ
ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ ΡΡΠ°Ρ
Π΅ΠΎΠ±ΡΠΎΠ½Ρ
ΠΈΠ°Π»ΡΠ½ΠΎΠ³ΠΎ Π΄Π΅ΡΠ΅Π²Π°, ΠΌΠ΅Π½ΡΡΠΈΠΌΠΈ ΡΡΠΎΠΊΠ°ΠΌΠΈ Π½Π°Ρ
ΠΎΠΆΠ΄Π΅Π½ΠΈΡ Π² ΠΠ ΠΠ’ Π² ΡΡΠ°Π²Π½Π΅Π½ΠΈΠΈ Ρ ΡΠ½Π΄ΠΎΡΡΠ°Ρ
Π΅Π°Π»ΡΠ½ΠΎΠΉ ΠΌΠ΅ΡΠΎΠ΄ΠΈΠΊΠΎΠΉ ΠΠΠ.ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΠΎΠ»ΡΡΠ΅Π½Π½ΡΠ΅ Π΄Π°Π½Π½ΡΠ΅ ΡΠ²ΠΈΠ΄Π΅ΡΠ΅Π»ΡΡΡΠ²ΡΡΡ ΠΎ Π²ΡΡΠΎΠΊΠΎΠΉ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ Π½Π΅ΠΈΠ½Π²Π°Π·ΠΈΠ²Π½ΠΎΠΉ ΠΠΠ ΠΈ ΡΠ»ΡΡΡΠ΅Π½ΠΈΠΈ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ² Π»Π΅ΡΠ΅Π½ΠΈΡ Π±ΠΎΠ»ΡΠ½ΡΡ
Ρ ΠΎΡΡΡΡΠΌ ΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΡΠΌ Π΄ΠΈΡΡΡΠ΅ΡΡ-ΡΠΈΠ½Π΄ΡΠΎΠΌΠΎΠΌ
ΠΠ»ΠΈΡΠ½ΠΈΠ΅ Π²ΡΡΠΎΠΊΠΎΠΉ ΡΠΏΠΈΠ΄ΡΡΠ°Π»ΡΠ½ΠΎΠΉ Π±Π»ΠΎΠΊΠ°Π΄Ρ Π½Π° ΡΡΠ½ΠΊΡΠΈΡ ΠΌΠΈΠΎΠΊΠ°ΡΠ΄Π° Π»Π΅Π²ΠΎΠ³ΠΎ ΠΆΠ΅Π»ΡΠ΄ΠΎΡΠΊΠ° ΠΏΠΎΡΠ»Π΅ Π°ΠΎΡΡΠΎ-ΠΊΠΎΡΠΎΠ½Π°ΡΠ½ΠΎΠ³ΠΎ ΡΡΠ½ΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ
Objective. To improve the outcomes of surgical treatment of coronary heart disease, by using high epidural block on the basis of evaluation of myocardial diastolic function in the preoperative and early postoperative periods. Materials and methods. 61 patients with coronary heart disease underwent coronary bypass surgery. According to the methods of analgesia, the patients were divided into 2 groups. A study group included 30 patients who had undergone high epidural block in the early postoperative period. A control group comprised 31 patients, wherein the conventional method for analgesia was applied through the parenteral administration of narcotic analgesics. Follow-up EchoCG was made, by examining the parameters of transmitral flow. The clinical course of a postoperative period and the length of stay in intensive care units were estimated. Results. Baseline diastolic dysfunction was detected in practically all patients. In the early postoperative period, the study group showed a significantly better myocardial diastolic function during high epidural block. In the control group, there was no improvement of the parameters characterizing left ventricular diastolic function. These patients longer stayed in a specialized intensive care unit. Conclusion. The postoperative employment of epidural block results in improved left ventricular diastolic function.Π¦Π΅Π»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ : ΡΠ»ΡΡΡΠΈΡΡ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΡ Ρ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΈΡΠ΅ΠΌΠΈΡΠ΅ΡΠΊΠΎΠΉ Π±ΠΎΠ»Π΅Π·Π½ΠΈ ΡΠ΅ΡΠ΄ΡΠ° Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ Π²ΡΡΠΎΠΊΠΎΠΉ ΡΠΏΠΈΠ΄ΡΡΠ°Π»ΡΠ½ΠΎΠΉ Π±Π»ΠΎΠΊΠ°Π΄Ρ Π½Π° ΠΎΡΠ½ΠΎΠ²Π°Π½ΠΈΠΈ ΠΎΡΠ΅Π½ΠΊΠΈ Π΄ΠΈΠ°ΡΡΠΎΠ»ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΡΠ½ΠΊΡΠΈΠΈ ΠΌΠΈΠΎΠΊΠ°ΡΠ΄Π° Π² ΠΏΡΠ΅Π΄ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΌ ΠΈ ΡΠ°Π½Π½Π΅ΠΌ ΠΏΠΎΡΠ»Π΅ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΌ ΠΏΠ΅ΡΠΈΠΎΠ΄Π°Ρ
.ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ: Π±ΠΎΠ»ΡΠ½ΡΠ΅ ΠΈΡΠ΅ΠΌΠΈΡΠ΅ΡΠΊΠΎΠΉ Π±ΠΎΠ»Π΅Π·Π½ΡΡ ΡΠ΅ΡΠ΄ΡΠ° (61 ΠΏΠ°ΡΠΈΠ΅Π½Ρ), ΠΊΠΎΡΠΎΡΡΠΌ Π±ΡΠ»Π° Π²ΡΠΏΠΎΠ»Π½Π΅Π½Π° ΠΎΠΏΠ΅ΡΠ°ΡΠΈΡ ΠΊΠΎΡΠΎΠ½Π°ΡΠ½ΠΎΠ³ΠΎ ΡΡΠ½ΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ. Π Π·Π°Π²ΠΈΡΠΈΠΌΠΎΡΡΠΈ ΠΎΡ ΠΌΠ΅ΡΠΎΠ΄ΠΈΠΊΠΈ Π°Π½Π°Π»ΡΠ³Π΅Π·ΠΈΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΡ Π±ΡΠ»ΠΈ ΡΠ°Π·Π΄Π΅Π»Π΅Π½Ρ Π½Π° 2 Π³ΡΡΠΏΠΏΡ. ΠΡΠ½ΠΎΠ²Π½ΡΡ Π³ΡΡΠΏΠΏΡ ΡΠΎΡΡΠ°Π²ΠΈΠ»ΠΈ 30 Π±ΠΎΠ»ΡΠ½ΡΡ
, ΠΊΠΎΡΠΎΡΡΠΌ Π² ΡΠ°Π½Π½Π΅ΠΌ ΠΏΠΎΡΠ»Π΅ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΌ ΠΏΠ΅ΡΠΈΠΎΠ΄Π΅ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»Π°ΡΡ Π²ΡΡΠΎΠΊΠ°Ρ ΡΠΏΠΈΠ΄ΡΡΠ°Π»ΡΠ½Π°Ρ Π±Π»ΠΎΠΊΠ°Π΄Π°. Π Π³ΡΡΠΏΠΏΠ΅ ΠΊΠΎΠ½ΡΡΠΎΠ»Ρ (31 ΠΏΠ°ΡΠΈΠ΅Π½Ρ) ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π»ΡΡ ΡΡΠ°Π΄ΠΈΡΠΈΠΎΠ½Π½ΡΠΉ ΠΌΠ΅ΡΠΎΠ΄ ΠΎΠ±Π΅Π·Π±ΠΎΠ»ΠΈΠ²Π°Π½ΠΈΡ ΠΏΠ°ΡΠ΅Π½ΡΠ΅ΡΠ°Π»ΡΠ½ΡΠΌ Π²Π²Π΅Π΄Π΅Π½ΠΈΠ΅ΠΌ Π½Π°ΡΠΊΠΎΡΠΈΡΠ΅ΡΠΊΠΈΡ
Π°Π½Π°Π»ΡΠ³Π΅ΡΠΈΠΊΠΎΠ². Π Π΄ΠΈΠ½Π°ΠΌΠΈΠΊΠ΅ Π²ΡΠΏΠΎΠ»Π½ΡΠ»ΠΎΡΡ ΠΠ₯Π-ΠΠ-ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅, ΠΏΡΠΈ ΠΊΠΎΡΠΎΡΠΎΠΌ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π»ΠΈΡΡ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ ΡΡΠ°Π½ΡΠΌΠΈΡΡΠ°Π»ΡΠ½ΠΎΠ³ΠΎ ΠΏΠΎΡΠΎΠΊΠ°. Π’Π°ΠΊΠΆΠ΅ ΠΎΡΠ΅Π½ΠΈΠ²Π°Π»ΠΈ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ ΠΏΠΎΡΠ»Π΅ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠ³ΠΎ ΠΏΠ΅ΡΠΈΠΎΠ΄Π° ΠΈ Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΡ ΠΏΡΠ΅Π±ΡΠ²Π°Π½ΠΈΡ Π² ΠΎΡΠ΄Π΅Π»Π΅Π½ΠΈΠΈ ΡΠ΅Π°Π½ΠΈΠΌΠ°ΡΠΈΠΈ.Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ: Π½Π°Π»ΠΈΡΠΈΠ΅ Π΄ΠΈ-Π°ΡΡΠΎΠ»ΠΈΡΠ΅ΡΠΊΠΎΠΉ Π΄ΠΈΡΡΡΠ½ΠΊΡΠΈΠΈ ΠΈΡΡ
ΠΎΠ΄Π½ΠΎ Π²ΡΡΠ²Π»Π΅Π½ΠΎ ΠΏΡΠ°ΠΊΡΠΈΡΠ΅ΡΠΊΠΈ Ρ Π²ΡΠ΅Ρ
Π±ΠΎΠ»ΡΠ½ΡΡ
. Π ΡΠ°Π½Π½Π΅ΠΌ ΠΏΠΎΡΠ»Π΅ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΌ ΠΏΠ΅ΡΠΈΠΎΠ΄Π΅ Π² ΠΎΡΠ½ΠΎΠ²Π½ΠΎΠΉ Π³ΡΡΠΏΠΏΠ΅ ΠΎΡΠΌΠ΅ΡΠ΅Π½ΠΎ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎΠ΅ ΡΠ»ΡΡΡΠ΅Π½ΠΈΠ΅ Π΄ΠΈΠ°ΡΡΠΎΠ»ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΡΠ½ΠΊΡΠΈΠΈ ΠΌΠΈΠΎΠΊΠ°ΡΠ΄Π° Π½Π° ΡΠΎΠ½Π΅ Π²ΡΡΠΎΠΊΠΎΠΉ ΡΠΏΠΈΠ΄ΡΡΠ°Π»Ρ-Π½ΠΎΠΉ Π±Π»ΠΎΠΊΠ°Π΄Ρ. Π Π³ΡΡΠΏΠΏΠ΅ ΠΊΠΎΠ½ΡΡΠΎΠ»Ρ ΡΠ»ΡΡΡΠ΅Π½ΠΈΡ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ, Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΠ·ΡΡΡΠΈΡ
Π΄ΠΈΠ°ΡΡΠΎΠ»ΠΈΡΠ΅ΡΠΊΡΡ ΡΡΠ½ΠΊΡΠΈΡ Π»Π΅Π²ΠΎΠ³ΠΎ ΠΆΠ΅Π»ΡΠ΄ΠΎΡΠΊΠ°, Π½Π΅ Π½Π°Π±Π»ΡΠ΄Π°Π»ΠΎΡΡ. ΠΡΠΈ Π±ΠΎΠ»ΡΠ½ΡΠ΅ ΡΠ°ΠΊΠΆΠ΅ ΡΡΠ΅Π±ΠΎΠ²Π°Π»ΠΈ Π±ΠΎΠ»Π΅Π΅ Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠ΅Π±ΡΠ²Π°Π½ΠΈΡ Π² ΡΠΏΠ΅ΡΠΈΠ°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΌ ΡΠ΅Π°Π½ΠΈΠΌΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΌ ΠΎΡΠ΄Π΅Π»Π΅Π½ΠΈΠΈ.ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅: ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ ΡΠΏΠΈΠ΄ΡΡΠ°Π»ΡΠ½ΠΎΠΉ Π±Π»ΠΎΠΊΠ°Π΄Ρ Π² ΠΏΠΎΡΠ»Π΅ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΌ ΠΏΠ΅ΡΠΈΠΎΠ΄Π΅ ΠΏΡΠΈΠ²ΠΎΠ΄ΠΈΡ ΠΊ ΡΠ»ΡΡΡΠ΅Π½ΠΈΡ Π΄ΠΈΠ°ΡΡΠΎΠ»ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΡΠ½ΠΊΡΠΈΠΈ ΠΌΠΈΠΎΠΊΠ°ΡΠ΄Π° Π»Π΅Π²ΠΎΠ³ΠΎ ΠΆΠ΅Π»ΡΠ΄ΠΎΡΠΊΠ°.
ECMO for COVID-19 patients in Europe and Israel
Since March 15th, 2020, 177 centres from Europe and Israel have joined the study, routinely reporting on the ECMO support they provide to COVID-19 patients. The mean annual number of cases treated with ECMO in the participating centres before the pandemic (2019) was 55. The number of COVID-19 patients has increased rapidly each week reaching 1531 treated patients as of September 14th. The greatest number of cases has been reported from France (n = 385), UK (n = 193), Germany (n = 176), Spain (n = 166), and Italy (n = 136) .The mean age of treated patients was 52.6 years (range 16β80), 79% were male. The ECMO configuration used was VV in 91% of cases, VA in 5% and other in 4%. The mean PaO2 before ECMO implantation was 65 mmHg. The mean duration of ECMO support thus far has been 18 days and the mean ICU length of stay of these patients was 33 days. As of the 14th September, overall 841 patients have been weaned from ECMO
support, 601 died during ECMO support, 71 died after withdrawal of ECMO, 79 are still receiving ECMO support and for 10 patients status n.a. . Our preliminary data suggest that patients placed
on ECMO with severe refractory respiratory or cardiac failure secondary to COVID-19 have a reasonable (55%) chance of survival. Further extensive data analysis is expected to provide invaluable information on the demographics, severity of illness, indications and different ECMO management strategies in these patients
The Organization of Extracorporeal Membrane Oxygenation Programs for Acute Respiratory Failure in Adult Patients in a multidisciplinary hospital. Review of Experience in Regensburg (Germany)
The article describes aspects of the organization and conduct of Extracorporeal Membrane Oxygenation (ECMO) in a multidisciplinary hospital for example, the University Hospital of Regensburg (Germany)
Respiratory Therapy for Acute Respiratory Distress Syndrome in Cardiosurgical Patients
The purpose of the present investigation was to improve the outcomes of intensive care in patients with acute respiratory distress syndrome after cardiac surgery under extracorporeal circulation.Materials and methods. Respiratory therapy was analyzed in 43 patients with acute respiratory distress syndrome after surgery under extracorporeal circulation. According to the procedure of artificial ventilation (AV), the patients were divided into 2 groups: 1) those who had undergone routine tracheal intubation (n=23) AND 2) THOSE who had received noninvasive intubation through a nasal mask (n=20). The respiratory parameters, blood gas composition, central hemodynamic parameters, respiratory support time, and the pattern of complications were analyzed.Results. Noninvasive artificial ventilation permits one to make the patients active in earlier periods and take a spontaneous breath, recovers the respiratory index earlier, reduces the level of positive end-expiratory pressure, the frequency of infectious complications of the tracheobronchial tree, and length of stay in an intensive care unit as compared with endotracheal AV.Conclusion. The findings suggest that noninvasive AV is highly effective and yields better results of treatment in patients with acute respiratory distress syndrome
ΠΡΠΎΡΠΈΡΠ½ΡΠ΅ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ COVID-19 ΠΊΡΠ°ΠΉΠ½Π΅ ΡΡΠΆΠ΅Π»ΠΎΠ³ΠΎ ΡΠ΅ΡΠ΅Π½ΠΈΡ Π²ΠΎ Π²ΡΠ΅ΠΌΡ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΡ ΠΠΠΠ
Up to 70% of patients hospitalized for COVID-19 need respiratory support, up to 10% need high-flow oxygen therapy, non-invasive and invasive ventilation. However, standard methods of respiratory support are ineffective in 0.4-0.5% of patients. In case of potentially reversible critical refractory respiratory failure that patients may require ECMO. Management of patients with extremely severe COVID-19 associates with numerous clinical challenges, including critical illness, multiple organ dysfunction, blood coagulation disorders, requiring prolonged ICU stay and care, use of multiple pharmacotherapies including immunosuppressive drugs. Pharmacological suppression of immunity is associated with a significant increase in the risk of secondary bacterial and fungal infections. Currently, data on epidemiology of secondary infections in patients with COVID-19 undergoing ECMO is limited.Aim. To study the prevalence and etiology of secondary infections associated with positive blood cultures in patients with extremely severe COVID-19 requiring ECMO.Materials and methods. A single-center retrospective non-interventional epidemiological study including 125 patients with extremely severe COVID-19 treated with ECMO in April 2020 to December 2021.Results. Out of 700 blood culture tests performed in 125 patients during the study, 250 tests were positive confirming bacteremia/fungemia. Isolated pathogens varied depending on the duration of ECMO: gram-positive bacteria (primarily coagulase-negative staphylococci) dominated from the initiation of ECMO support; increased duration of ECMO associated with an increasing the proportion of pathogens common in ICU (Klebsiella pneumoniae and/or Acinetobacter baumannii with extensively drug resistant and pan-drug resistant phenotypes, and vancomycin-resistant Enterococcus faecium). When ECMO lasted more than 7-14 days, opportunistic pathogens (Candida species, Stenotrophomonas maltophilia, Providencia stuartii, non-diphtheria corynebacteria, Burkholderia species and others) prevailed as etiological agents.Conclusion. Longer duration of ECMO resulted in increasing the rates of infectious complications. In patients undergoing ECMO for more than 14 days, the microbiological landscape becomes extremely diverse, which hampers choosing an empirical antimicrobial therapy. Since potential pathogens causing secondary infections in patients during ECMO are difficult to predict, rapid identification of rare opportunistic pathogens and their sensitivity profile, followed by targeted administration of antimicrobials, seems most beneficial.Β ΠΠΎ 70% Π³ΠΎΡΠΏΠΈΡΠ°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
ΠΏΠΎ ΠΏΠΎΠ²ΠΎΠ΄Ρ COVID-19 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π½ΡΠΆΠ΄Π°ΡΡΡΡ Π² ΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΠΎΠΉ ΠΏΠΎΠ΄Π΄Π΅ΡΠΆΠΊΠ΅, Π΄ΠΎ 10% β Π² ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠΈ Π²ΡΡΠΎΠΊΠΎΠΏΠΎΡΠΎΡΠ½ΠΎΠΉ ΠΎΠΊΡΠΈΠ³Π΅Π½ΠΎΡΠ΅ΡΠ°ΠΏΠΈΠΈ, Π½Π΅ΠΈΠ½Π²Π°Π·ΠΈΠ²Π½ΠΎΠΉ ΠΈ ΠΈΠ½Π²Π°Π·ΠΈΠ²Π½ΠΎΠΉ Π²Π΅Π½ΡΠΈΠ»ΡΡΠΈΠΈ Π»Π΅Π³ΠΊΠΈΡ
, Ρ 0,4-0,5% ΡΡΠ°Π½Π΄Π°ΡΡΠ½ΡΠ΅ ΡΠΏΠΎΡΠΎΠ±Ρ ΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΠΎΠΉ ΠΏΠΎΠ΄Π΄Π΅ΡΠΆΠΊΠΈ Π½Π΅ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½Ρ. Π ΡΠ»ΡΡΠ°Π΅ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΏΠΎΡΠ΅Π½ΡΠΈΠ°Π»ΡΠ½ΠΎ ΠΎΠ±ΡΠ°ΡΠΈΠΌΠΎΠΉ ΠΊΡΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠ΅ΡΡΠ°ΠΊΡΠ΅ΡΠ½ΠΎΠΉ Π΄ΡΡ
Π°ΡΠ΅Π»ΡΠ½ΠΎΠΉ Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΎΡΠ½ΠΎΡΡΠΈ ΡΠ΅ΠΊΠΎΠΌΠ΅Π½Π΄ΡΠ΅ΡΡΡ ΡΠ°ΡΡΠΌΠΎΡΡΠ΅Π½ΠΈΠ΅ Π²ΠΎΠΏΡΠΎΡΠ° ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΠΠΠ. ΠΠ΅Π΄Π΅Π½ΠΈΠ΅ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΠΊΡΠ°ΠΉΠ½Π΅ ΡΡΠΆΠ΅Π»ΡΠΌ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ΠΌ COVID-19 ΡΠΎΠΏΡΠΎΠ²ΠΎΠΆΠ΄Π°Π΅ΡΡΡ Π±ΠΎΠ»ΡΡΠΈΠΌ ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²ΠΎΠΌ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΡΡΠ΄Π½ΠΎΡΡΠ΅ΠΉ: ΠΊΡΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΡΠΎΡΡΠΎΡΠ½ΠΈΠ΅, ΠΌΡΠ»ΡΡΠΈΠΎΡΠ³Π°Π½Π½ΠΎΠ΅ ΠΏΠΎΡΠ°ΠΆΠ΅Π½ΠΈΠ΅, Π½Π°ΡΡΡΠ΅Π½ΠΈΡ ΡΠΈΡΡΠ΅ΠΌΡ Π³Π΅ΠΌΠΎΡΡΠ°Π·Π°, Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎΡΡΡ Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠ΅Π±ΡΠ²Π°Π½ΠΈΡ Π² ΠΠ ΠΠ’, ΡΠΎΠΏΡΡΡΡΠ²ΡΡΡΠ°Ρ ΡΠ΅ΡΠ°ΠΏΠΈΡ (Π² ΡΠΎΠΌ ΡΠΈΡΠ»Π΅ ΠΈΠΌΠΌΡΠ½ΠΎΡΡΠΏΡΠ΅ΡΡΠΈΠ²Π½Π°Ρ). ΠΠ΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΠΎΠ΅ ΠΏΠΎΠ΄Π°Π²Π»Π΅Π½ΠΈΠ΅ ΠΈΠΌΠΌΡΠ½ΠΈΡΠ΅ΡΠ° ΡΠΎΠΏΡΠΎΠ²ΠΎΠΆΠ΄Π°Π΅ΡΡΡ Π·Π½Π°ΡΠΈΡΠ΅Π»ΡΠ½ΡΠΌ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΠ΅ΠΌ ΡΠΈΡΠΊΠ° ΡΠ°Π·Π²ΠΈΡΠΈΡ Π²ΡΠΎΡΠΈΡΠ½ΡΡ
ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΎΠ½Π½ΡΡ
ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ β Π² ΠΏΠ΅ΡΠ²ΡΡ ΠΎΡΠ΅ΡΠ΅Π΄Ρ Π±Π°ΠΊΡΠ΅ΡΠΈΠ°Π»ΡΠ½ΡΡ
ΠΈ Π³ΡΠΈΠ±ΠΊΠΎΠ²ΡΡ
. Π Π½Π°ΡΡΠΎΡΡΠ΅Π΅ Π²ΡΠ΅ΠΌΡ ΠΈΠΌΠ΅ΡΡΡΡ ΠΎΠ³ΡΠ°Π½ΠΈΡΠ΅Π½Π½ΡΠ΅ Π΄Π°Π½Π½ΡΠ΅ ΠΎΠ± ΡΠΏΠΈΠ΄Π΅ΠΌΠΈΠΎΠ»ΠΎΠ³ΠΈΠΈ Π²ΡΠΎΡΠΈΡΠ½ΡΡ
ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΉ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ COVID-19, ΠΊΠΎΡΠΎΡΡΠΌ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΡΡΡ ΠΠΠΠ.Π¦Π΅Π»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ. ΠΠ·ΡΡΠ΅Π½ΠΈΠ΅ ΡΠ°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½Π½ΠΎΡΡΠΈ ΠΈ ΡΡΠΈΠΎΠ»ΠΎΠ³ΠΈΠΈ Π²ΡΠΎΡΠΈΡΠ½ΡΡ
ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΉ, ΡΠΎΠΏΡΠΎΠ²ΠΎΠΆΠ΄Π°ΡΡΠΈΡ
ΡΡ Π²ΡΠ΄Π΅Π»Π΅Π½ΠΈΠ΅ΠΌ ΠΏΠ°ΡΠΎΠ³Π΅Π½ΠΎΠ² ΠΈΠ· ΠΊΡΠΎΠ²ΠΈ, ΡΠ°Π·Π²ΠΈΠ²ΡΠΈΡ
ΡΡ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ COVID-19 ΠΊΡΠ°ΠΉΠ½Π΅ ΡΡΠΆΠ΅Π»ΠΎΠ³ΠΎ ΡΠ΅ΡΠ΅Π½ΠΈΡ, ΡΡΠ΅Π±ΡΡΡΠΈΡ
ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΡ ΠΠΠΠ.ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΠ΄Π½ΠΎΡΠ΅Π½ΡΡΠΎΠ²ΠΎΠ΅ ΡΠ΅ΡΡΠΎΡΠΏΠ΅ΠΊΡΠΈΠ²Π½ΠΎΠ΅ Π½Π΅ΠΈΠ½ΡΠ΅ΡΠ²Π΅Π½ΡΠΈΠΎΠ½Π½ΠΎΠ΅ ΡΠΏΠΈΠ΄Π΅ΠΌΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Ρ 125 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ COVID-19 ΠΊΡΠ°ΠΉΠ½Π΅ ΡΡΠΆΠ΅Π»ΠΎΠ³ΠΎ ΡΠ΅ΡΠ΅Π½ΠΈΡ, ΠΊΠΎΡΠΎΡΡΠΌ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ ΠΠΠΠ Π² ΠΏΠ΅ΡΠΈΠΎΠ΄ Ρ Π°ΠΏΡΠ΅Π»Ρ 2020 Π³ΠΎΠ΄Π° Π΄ΠΎ Π΄Π΅ΠΊΠ°Π±ΡΡ 2021 Π³ΠΎΠ΄Π°.Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. 125 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ°ΠΌ ΠΏΡΠΎΠ²Π΅Π»ΠΈ 700 ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ ΠΊΡΠΎΠ²ΠΈ Π½Π° ΡΡΠ΅ΡΠΈΠ»ΡΠ½ΠΎΡΡΡ. ΠΠ°ΠΊΡΠ΅ΡΠΈΠ΅ΠΌΠΈΡ/ΡΡΠ½Π³Π΅ΠΌΠΈΡ Π²ΡΡΠ²ΠΈΠ»ΠΈ Π² 250 ΡΠ»ΡΡΠ°ΡΡ
. Π Π·Π°Π²ΠΈΡΠΈΠΌΠΎΡΡΠΈ ΠΎΡ ΡΡΠΎΠΊΠΎΠ² ΠΠΠΠ ΠΌΠ΅Π½ΡΠ»Π°ΡΡ ΡΡΡΡΠΊΡΡΡΠ° ΠΏΠ°ΡΠΎΠ³Π΅Π½ΠΎΠ²: Π² Π΄Π΅Π±ΡΡΠ΅ Π²Π΅Π΄ΡΡΠΈΠΌΠΈ Π²ΠΎΠ·Π±ΡΠ΄ΠΈΡΠ΅Π»ΡΠΌΠΈ Π²ΡΡΡΡΠΏΠ°Π»ΠΈ Π³ΡΠ°ΠΌΠΏΠΎΠ»ΠΎΠΆΠΈΡΠ΅Π»ΡΠ½ΡΠ΅ ΠΏΠ°ΡΠΎΠ³Π΅Π½Ρ (Π² ΠΏΠ΅ΡΠ²ΡΡ ΠΎΡΠ΅ΡΠ΅Π΄Ρ β ΠΊΠΎΠ°Π³ΡΠ»Π°Π·ΠΎΠ½Π΅Π³Π°ΡΠΈΠ²Π½ΡΠ΅ ΡΡΠ°ΡΠΈΠ»ΠΎΠΊΠΎΠΊΠΊΠΈ), ΠΏΡΠΈ ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ΠΈΠΈ ΠΏΡΠΎΠ΄ΠΎΠ»ΠΆΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ ΠΠΠΠ ΡΠ²Π΅Π»ΠΈΡΠΈΠ²Π°Π»Π°ΡΡ Π΄ΠΎΠ»Ρ Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠ½ΡΡ
Π΄Π»Ρ ΠΠ ΠΠ’ Π²ΠΎΠ·Π±ΡΠ΄ΠΈΡΠ΅Π»Π΅ΠΉ (Klebsiella pneumoniae, Acinetobacter baumannii Ρ ΡΠ΅Π½ΠΎΡΠΈΠΏΠ°ΠΌΠΈ ΡΠΊΡΡΡΠ΅ΠΌΠ°Π»ΡΠ½ΠΎΠΉ ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΠΎΡΡΠΈ ΠΈ ΠΏΠ°Π½ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΠΎΡΡΠΈ, Π²Π°Π½ΠΊΠΎΠΌΠΈΡΠΈΠ½ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΡΠΉ Enterococcus faecium). ΠΡΠΈ ΠΏΡΠΎΠ΄ΠΎΠ»ΠΆΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ ΠΠΠΠ Π±ΠΎΠ»Π΅Π΅ 7-14 ΡΡΡΠΎΠΊ Π·Π½Π°ΡΠΈΠΌΡΡ ΡΠΎΠ»Ρ ΠΈΠ³ΡΠ°Π»ΠΈ ΠΎΠΏΠΏΠΎΡΡΡΠ½ΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΠ°ΡΠΎΠ³Π΅Π½Ρ (Candida species, Stenotrophomonas maltophilia, Providencia stuartii, Π½Π΅Π΄ΠΈΡΡΠ΅ΡΠΈΠΉΠ½ΡΠ΅ ΠΊΠΎΡΠΈΠ½Π΅Π±Π°ΠΊΡΠ΅ΡΠΈΠΈ, Burkholderia species ΠΈ Π΄ΡΡΠ³ΠΈΠ΅).ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΡΠΈ ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ΠΈΠΈ ΡΡΠΎΠΊΠΎΠ² ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΡ ΠΠΠΠ ΠΏΡΠΎΠ³ΡΠ΅ΡΡΠΈΠ²Π½ΠΎ Π½Π°ΡΠ°ΡΡΠ°Π΅Ρ ΡΠ°ΡΡΠΎΡΠ° ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΎΠ½Π½ΡΡ
ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ. ΠΡΠΈ ΠΏΡΠΎΠ΄ΠΎΠ»ΠΆΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ ΠΠΠΠ Π±ΠΎΠ»Π΅Π΅ 14 ΡΡΡΠΎΠΊ ΠΌΠΈΠΊΡΠΎΠ±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΉ ΠΏΠ΅ΠΉΠ·Π°ΠΆ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΡΡΠ°Π½ΠΎΠ²ΠΈΡΡΡ ΡΡΠ΅Π·Π²ΡΡΠ°ΠΉΠ½ΠΎ ΡΠ°Π·Π½ΠΎΠΎΠ±ΡΠ°Π·Π½ΡΠΌ, ΡΡΠΎ Π·Π°ΡΡΡΠ΄Π½ΡΠ΅Ρ Π²ΡΠ±ΠΎΡ ΡΠΌΠΏΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ Π°Π½ΡΠΈΠΌΠΈΠΊΡΠΎΠ±Π½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ. ΠΡΠ»Π΅Π΄ΡΡΠ²ΠΈΠ΅ ΡΠΎΠ³ΠΎ, ΡΡΠΎ ΡΠΏΠ΅ΠΊΡΡ Π²ΠΎΠ·Π±ΡΠ΄ΠΈΡΠ΅Π»Π΅ΠΉ Π²ΡΠΎΡΠΈΡΠ½ΡΡ
ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΉ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π²ΠΎ Π²ΡΠ΅ΠΌΡ ΠΠΠΠ ΡΡΠ°Π½ΠΎΠ²ΠΈΡΡΡ ΡΡΡΠ΄Π½ΠΎΠΏΡΠ΅Π΄ΡΠΊΠ°Π·ΡΠ΅ΠΌΡΠΌ, Π±ΡΡΡΡΠ°Ρ ΠΈΠ΄Π΅Π½ΡΠΈΡΠΈΠΊΠ°ΡΠΈΡ ΡΠ΅Π΄ΠΊΠΈΡ
ΠΎΠΏΠΏΠΎΡΡΡΠ½ΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΠ°ΡΠΎΠ³Π΅Π½ΠΎΠ² ΠΈ ΠΈΡ
ΠΏΡΠΎΡΠΈΠ»Ρ ΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ, ΡΠ΅Π»Π΅Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½Π½ΠΎΠ΅ Π½Π°Π·Π½Π°ΡΠ΅Π½ΠΈΠ΅ Π°Π½ΡΠΈΠΌΠΈΠΊΡΠΎΠ±Π½ΡΡ
ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ² ΠΏΡΠΈΠ½ΠΎΡΠΈΡ Π½Π°ΠΈΠ±ΠΎΠ»ΡΡΡΡ ΠΏΠΎΠ»ΡΠ·Ρ
In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational study
Background: Extracorporeal membrane oxygenation (ECMO) has been widely used in patients with COVID-19, but uncertainty remains about the determinants of in-hospital mortality and data on post-discharge outcomes are scarce. The aims of this study were to investigate the variables associated with in-hospital outcomes in patients who received ECMO during the first wave of COVID-19 and to describe the status of patients 6 months after ECMO initiation. Methods: EuroECMO-COVID is a prospective, multicentre, observational study developed by the European Extracorporeal Life Support Organization. This study was based on data from patients aged 16 years or older who received ECMO support for refractory COVID-19 during the first wave of the pandemicβfrom March 1 to Sept 13, 2020βat 133 centres in 21 countries. In-hospital mortality and mortality 6 months after ECMO initiation were the primary outcomes. Mixed-Cox proportional hazards models were used to investigate associations between patient and management-related variables (eg, patient demographics, comorbidities, pre-ECMO status, and ECMO characteristics and complications) and in-hospital deaths. Survival status at 6 months was established through patient contact or institutional charts review. This study is registered with ClinicalTrials.gov, NCT04366921, and is ongoing. Findings: Between March 1 and Sept 13, 2020, 1215 patients (942 [78%] men and 267 [22%] women; median age 53 years [IQR 46β60]) were included in the study. Median ECMO duration was 15 days (IQR 8β27). 602 (50%) of 1215 patients died in hospital, and 852 (74%) patients had at least one complication. Multiorgan failure was the leading cause of death (192 [36%] of 528 patients who died with available data). In mixed-Cox analyses, age of 60 years or older, use of inotropes and vasopressors before ECMO initiation, chronic renal failure, and time from intubation to ECMO initiation of 4 days or more were associated with higher in-hospital mortality. 613 patients did not die in hospital, and 547 (95%) of 577 patients for whom data were available were alive at 6 months. 102 (24%) of 431 patients had returned to full-time work at 6 months, and 57 (13%) of 428 patients had returned to part-time work. At 6 months, respiratory rehabilitation was required in 88 (17%) of 522 patients with available data, and the most common residual symptoms included dyspnoea (185 [35%] of 523 patients) and cardiac (52 [10%] of 514 patients) or neurocognitive (66 [13%] of 512 patients) symptoms. Interpretation: Patient's age, timing of cannulation (<4 days vs β₯4 days from intubation), and use of inotropes and vasopressors are essential factors to consider when analysing the outcomes of patients receiving ECMO for COVID-19. Despite post-discharge survival being favourable, persisting long-term symptoms suggest that dedicated post-ECMO follow-up programmes are required. Funding: None